Vericel (VCEL) Total Debt (QoQ) (2011 - 2018)
Vericel (VCEL) Total Debt (QoQ) (2011 - 2018) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Vericel | 2.26 Bn | 2.10 Bn | 56.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 0.09% |
| Jun 30, 2018 | 0.10% |
| Mar 31, 2018 | 0.05% |
| Dec 31, 2017 | 73.12% |
| Sep 30, 2017 | -1.92% |
| Jun 30, 2017 | 0.27% |
| Mar 31, 2017 | 1,148.46% |
| Dec 31, 2016 | -85.54% |
| Sep 30, 2016 | 10,684.62% |
| Jun 30, 2016 | -16.13% |
| Mar 31, 2016 | -12.68% |
| Dec 31, 2015 | -12.35% |
| Sep 30, 2015 | -10.99% |
| Jun 30, 2015 | -9.00% |
| Mar 31, 2015 | -78.12% |
| Dec 31, 2014 | 198.69% |
| Sep 30, 2014 | -93.88% |
| Jun 30, 2014 | 124,900.00% |
| Mar 31, 2014 | -66.67% |
| Dec 31, 2013 | -40.00% |